News
-
-
REGULATED PRESS RELEASE
Déclaration du nombre d'actions composant le capital et du nombre total de droits de vote au 31 janvier 2025
EURAZEO communique le nombre d'actions et de droits de vote au 31 janvier 2025, illustrant sa solide structure financière. Découvrez les détails et sa stratégie d'investissement -
REGULATED PRESS RELEASE
Disclosure of the number of shares and the total number of voting rights as of January 31, 2025
Eurazeo discloses total shares and voting rights. Leading European investment group with diverse assets of 35.5 billion euros, focusing on private equity, private debt, real estate, and infrastructure -
PRESS RELEASE
Cherry switch business and Cherry Americas below expectations. 2024 annual results of Cherry SE below plan - focus on growth in 2025
Cherry SE reports below-plan 2024 results due to challenges in Americas & switch business. Focus on growth in 2025 amid strategic realignment & cost management -
PRESS RELEASE
vVARDIS Announces $35 Million Financing with Global Healthcare Investor OrbiMed to Roll Out Curodont, an Innovative Drill-Free Treatment for Early Tooth Decay
vVARDIS secures $35 million financing from OrbiMed to expand global commercial reach with innovative drill-free treatment for early tooth decay under Curodont brand -
-
-
-
-